FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11556511000001103: Tarceva 25mg tablets (Roche Products Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42357101000001112 Tarceva 25mg tablets (Roche Products Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42357201000001117 Tarceva 25mg tablets (Roche Products Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Is a Erlotinib 25mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Is pack of Tarceva 25mg tablets (Roche Products Ltd) false Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has active ingredient Erlotinib false Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has AMP Tarceva 25mg tablets (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erlotinib true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has specific active ingredient Erlotinib hydrochloride true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Tarceva 25mg tablets (Roche Products Ltd) 30 tablet Has basis of strength substance Erlotinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start